<DOC>
	<DOCNO>NCT01089244</DOCNO>
	<brief_summary>The aim study compare two image modality perfusion weight MR-imaging FET-PET ability provide accurate histological evaluation low grade glioma reveal focal abnormality within homogeneously appear tumor . Additionally , therapeutic effect assessed time period two year .</brief_summary>
	<brief_title>FET-PET Diagnosis Monitoring Patients With Low Grade Glioma</brief_title>
	<detailed_description />
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Astrocytoma</mesh_term>
	<mesh_term>Oligodendroglioma</mesh_term>
	<criteria>neuroradiologically suspect low grade glioma ( Astrocytoma WHOIII , Oligodendroglioma WHO II , Oligoastrocytoma WHO II ) histological verification obtain either microsurgery stereotactic biopsy patient older 18 year Karnofsky Performance Score &gt; =70 pregnant nursing female patient include study patient informed consent obtain due organic brain syndrome insufficient language skill patient lie quiet time period app . two hour FETPEt scan medical history metastatic brain disease patient MRI scan perform due claustrophobia metallic protheses pacemaker etc .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Low grade glioma</keyword>
	<keyword>Astrocytoma</keyword>
	<keyword>Molecular imaging</keyword>
	<keyword>FET PET</keyword>
	<keyword>Therapy monitoring</keyword>
	<keyword>Temodar</keyword>
</DOC>